Quest PharmaTech Inc (CVE:QPT) shares fell 8% during mid-day trading on Wednesday . The stock traded as low as C$0.12 and last traded at C$0.12, 5,000 shares traded hands during trading. A decline of 83% from the average session volume of 30,137 shares. The stock had previously closed at C$0.13.
The stock has a market cap of $21.76 million and a PE ratio of -3.83. The business’s 50 day moving average price is C$0.13.
Quest PharmaTech (CVE:QPT) last issued its quarterly earnings results on Thursday, May 30th. The company reported C($0.01) earnings per share (EPS) for the quarter. The company had revenue of C$0.01 million during the quarter.
Quest PharmaTech Inc, a biotechnology company, develops and commercializes antibody based immunotherapeutic products for cancer. It operates in two segments, Biopharmaceutical/Pharmaceutical Products and Consumer/Cosmetic Products. The company focuses on combinatorial immunotherapeutic approaches to cancer by using monoclonal antibodies of the immunoglobulin G or E subclass in combination with chemotherapy/immune-adjuvant.
Featured Story: What is meant by holder of record?
Receive News & Ratings for Quest PharmaTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quest PharmaTech and related companies with MarketBeat.com's FREE daily email newsletter.